ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Towards a Compositional Framework for Describing Human Phenotypes.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Deep phenotyping increasingly spans scales from macro to micro, yet heterogeneity in measurement and documentation still constrains standardization and limits comparability across cohorts. This study introduces a compositional framework that integrates the Phenotype Assembly Method (PhenoAM), Phenome Data Elements (PhenoDE), and a suite of large language model (LLM)-based PhenoAgents to support systematic, interpretable, and scalable phenotype standardization with quality assessment. PhenoAM decomposes phenotype descriptions into features and qualifiers to enable component-level mapping, while PhenoDE provides standardized representations of 58 371 phenotype data elements across 22 measurement platforms of the International Human Phenome Project (IHPP); pooled mapping coverage was 98.1% within the 18-platform analysis set and 99.8% across all 22 platforms. Using this representation, analyses of illustrative phenotypes from IHPP, National Health and Nutrition Examination Survey (NHANES), and the UK Biobank show that differences in features or qualifiers can influence data distributions and analytic outcomes, underscoring the importance of explicit measurement context in cross-cohort studies. PhenoAgents support semantic parsing, terminology candidate retrieval, and data-quality review through curator-assisted modules. PhenoDEs and their statistical distributions within IHPP are accessible on the PhenoDE Portal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.